Where to Take a GLP-1 Shot: A Comprehensive Guide to Semaglutide Injections

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections work best when administered consistently to the same general body regions while rotating specific spots to prevent tissue damage. Proper injection technique reduces bruising, lipohypertrophy, and injection-site reactions that can affect medication absorption and patient adherence.

Best Anatomical Sites for Semaglutide Injection Administration

The abdomen, thigh, and upper arm are the three FDA-designated regions for subcutaneous GLP-1 administration. Each site offers distinct advantages: the abdomen provides the fastest absorption due to higher blood flow, the thigh allows easy self-access and visibility, and the upper arm offers convenience for patients who prefer injecting through clothing. PlexusDx recommends selecting one primary region per week, then rotating to a different region the following week to allow tissue recovery.

Within each region, specific landmarks guide safe needle placement. On the abdomen, inject at least 2 inches away from the navel and avoid the area directly above the groin or ribs. On the thigh, target the outer mid-thigh area between hip and knee, staying away from veins and bone. On the upper arm, inject on the back of the arm between shoulder and elbow, in the space where you can pinch an inch of skin. These anatomical guidelines reduce the risk of hitting blood vessels or nerves.

Understanding Injection Depth and Needle Techniques

Semaglutide uses a 31-gauge needle designed for subcutaneous (not intramuscular) injection, meaning the medication should deposit in the fatty tissue layer just below the skin, not into muscle. To ensure correct depth, hold the syringe or pen at a 90-degree angle to your skin, pinch a fold of tissue between thumb and fingers, and insert the needle straight into that fold until it fully enters. Most patients find this approach easier than angled injections because it creates a consistent subcutaneous pocket.

After the needle enters, inject slowly over 3–5 seconds to allow the medication to distribute evenly and minimize pressure buildup in surrounding tissues. Some patients experience less discomfort when they count slowly or take a deep breath during injection. Remove the needle straight out without twisting, and apply gentle pressure with a clean gauze pad for 5–10 seconds if bleeding occurs. Rubbing the injection site afterward can increase bruising, so avoid massage and let the area settle naturally.

Rotation Schedules to Prevent Tissue Damage and Lipohypertrophy

Rotating injection sites is not optional—it is a clinical best practice that prevents lipohypertrophy (abnormal fat buildup) and lipoatrophy (fat loss) at frequently used spots. A standard rotation pattern uses four main sites within a region: for the abdomen, inject at upper-left, upper-right, lower-left, and lower-right quadrants, spacing each site at least 1 inch apart. Maintain at least 1 week between injections at the same exact spot, and ideally 4 weeks before returning to that location.

Many patients find a weekly rotation map helpful: Week 1 abdomen (spot A), Week 2 thigh (spot A), Week 3 upper arm (spot A), Week 4 abdomen (spot B), and so on. This system ensures that each spot rests for three weeks while other regions receive the injection. Patients on higher doses or longer treatment durations should pay special attention to rotation because cumulative tissue exposure increases the risk of injection-site complications. PlexusDx recommends marking potential sites on your body or using a printed rotation chart during your first month of therapy.

Managing Injection Discomfort and Common Site Reactions

Minor injection-site reactions—such as redness, mild swelling, or bruising—occur in some patients but typically resolve within 24–48 hours. To minimize discomfort before injection, allow the pen or syringe to reach room temperature for 15–30 minutes (do not microwave), wash your hands with soap and water, and select a relaxed environment where you can sit or lie down. A cold compress applied 1–2 minutes before injection can numb the area and reduce discomfort, while a warm compress after injection may ease soreness.

If bruising becomes frequent despite proper rotation, several strategies can help: inject more slowly, avoid sites with visible veins or scars, ensure your pinch technique creates adequate subcutaneous depth, and verify you are using the correct needle angle. Some patients report that injecting at night allows them to rest the area without pressure. Persistent large bruises, warmth, redness lasting over 3 days, or signs of infection (increasing pain, pus, fever) warrant contact with your prescribing provider. PlexusDx patients have access to guidance from licensed pharmacists who can review injection technique and troubleshoot complications.

How Precision Genetic Testing Influences GLP-1 Response and Dosing

Individual genetics play a significant role in how your body responds to semaglutide injections, including metabolic rate, appetite regulation, and medication effectiveness. The PlexusDx Precision Peptide Genetic Test analyzes key variants in GLP1R, GIPR, FTO, and MC4R genes that influence peptide signaling pathways controlling hunger and weight loss. Understanding your genetic profile helps your PlexusDx provider predict which patients may benefit most from semaglutide versus tirzepatide, or whether a combination approach (GLP-Squared) offers better outcomes.

Genetic insights do not change your injection technique, but they do inform dose progression and treatment expectations. Some patients with favorable GLP1R receptor variants experience significant appetite suppression at lower doses, while others with different genetic profiles may require higher doses to achieve similar metabolic benefits. PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after your first month of treatment, allowing your provider to refine your therapy based on both your clinical response and your unique peptide-pathway genetics. This personalized approach maximizes efficacy while keeping your monthly cost flat regardless of dose adjustments.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week?

No, injecting in the same spot repeatedly increases the risk of lipohypertrophy (abnormal fat buildup) and can reduce medication absorption. PlexusDx recommends rotating sites weekly across different body regions, waiting at least 4 weeks before returning to any specific injection spot.

What happens if I inject semaglutide into muscle instead of fat?

Intramuscular injection can cause pain, tissue damage, and unpredictable medication absorption. Semaglutide is designed for subcutaneous (under-skin) delivery only. Using the correct needle angle, pinching a tissue fold, and injecting at 90 degrees ensures the medication reaches the fatty tissue layer where it works best.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx Compounded Semaglutide Injection starts at $149 per month and remains flat regardless of your dose level—your dose may need to go up, but your price won't. All medications come from licensed 503A compounding pharmacies, require no insurance, and are HSA/FSA eligible.

Is bleeding or bruising after a semaglutide injection normal?

Minor bleeding or bruising can occur but typically resolves within 24–48 hours. To reduce bruising, apply a cold compress before injection, inject slowly, use proper rotation sites, and avoid rubbing the area afterward. Persistent large bruises or signs of infection should be reported to your provider.

How does the PlexusDx genetic test help with semaglutide treatment?

The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite and weight-loss response. Results help your PlexusDx provider predict optimal medication selection, estimate dose requirements, and determine if a dual-compound option like GLP-Squared may work better for your genetic profile.